Canadian Cancer Trials Group Bulletins

Trial Management Group

Trial Milestone: CX.5(SHAPE)

CX.5 (SHAPE) a Randomized Phase III Trial Comparing Radical Hysterectomy and Pelvic Node Dissection vs Simple Hysterectomy and Pelvic Node Dissection in Patients with Low-Risk, Early-Stage, Cervical Cancer.

CCTG would like to recognize a huge CX.5 (SHAPE) milestone, together with participating sites we have reached the halfway point for the total accrual of 350 patients for this important trial!

A record-breaking 17 patients were randomized to SHAPE in June alone.

A special nod to Dr. Vanessa Samouelian and her team at CHUM - Hopital Notre-Dame in Montreal QC who are leading the way with 30 patients enrolled thus far. WOW!

On behalf of the SHAPE trial committee, we would like to thank you all for your tremendous support of this trial.

If you have any questions or are looking for more information about this trial please contact: Andrea Hiltz, Study Coordinator,